$TYRA 8-K SEC Filings

Filed On	Filing
15 Sep 2026	8-K: Other Events Tyra Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement with Jefferies LLC, Guggenheim Securities, LLC, Cantor Fitzgerald & Co., Barclays Capital Inc. and each of the other Underwriters named in Schedule A ...
09 Sep 2026	8-K: Other Events On September 9, 2026, Tyra Biosciences, Inc. (TYRA or the Company) announced initial results from SURF302, its Phase 2 study evaluating oral dabogratinib in patients with Fibroblast Growth Factor Receptor (FGFR) 3-altered low-grade inter...
04 Aug 2026	8-K: Results of Operations and Financial Condition
02 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
13 May 2026	8-K: Results of Operations and Financial Condition
17 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
02 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation
04 Mar 2026	8-K: Other Events
02 Mar 2026	8-K: Results of Operations and Financial Condition
01 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
05 Nov 2025	8-K: Results of Operations and Financial Condition
22 Aug 2025	8-K: Other Events
14 Aug 2025	8-K: Results of Operations and Financial Condition
30 Jun 2025	8-K: Other Events
29 May 2025	8-K: Submission of Matters to a Vote of Security Holders
08 May 2025	8-K: Results of Operations and Financial Condition
27 Mar 2025	8-K: Results of Operations and Financial Condition
29 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation
07 Nov 2024	8-K: Results of Operations and Financial Condition
28 Oct 2024	8-K: Other Events

Comments